Suncare Traders Ltd (539526)

Suncare Traders Ltd has submitted its quarterly statement of deviation or variation under Regulation 32(1) of SEBI LODR Regulations for the period ended September 30, 2026. The company confirmed that it has no unutilized funds remaining from any public, rights, preferential issues, or QIPs as of September 30, 2026, or as of the filing date. Consequently, no Annexure-A statement of deviation was required to be submitted. This is a standard procedural regulatory filing with no financial impact.

• No funds remain unutilized as on September 30, 2026, or as of November 3, 2026.
• Disclosure covers past public, rights, preferential issues, or Qualified Institutional Placements (QIPs).
• No deviation statement (Annexure-A) was provided as there are no active unutilized issue proceeds.

Suncare Traders reported standalone results for the quarter ended September 30, 2026, recording ₹0 in operational revenue and relying solely on Other Income of ₹41.52 lakh. Net Profit for the quarter stood at ₹22.02 lakh compared to a loss of ₹111.90 lakh in Q2 FY26. For the six-month period ended September 30, 2026, net profit was ₹52.44 lakh with other income at ₹92.93 lakh and zero core revenue. Basic EPS for the quarter came in at ₹0.04 on a paid-up equity share capital of ₹5,100 lakh.

• Revenue from operations was nil (₹0.00) for both Q2 FY27 and Q1 FY27
• Other income drove total revenue, coming in at ₹41.52 lakh vs ₹261.86 lakh in Q2 FY26
• Net profit after tax for Q2 stood at ₹22.02 lakh vs a net loss of ₹111.90 lakh in the year-ago period
• H1 FY27 Net Profit reported at ₹52.44 lakh compared to a loss of ₹16.01 lakh in H1 FY26
• Paid-up equity share capital remained constant at ₹5,100.00 lakh

Suncare Traders Ltd has submitted its quarterly statement of deviation or variation under Regulation 32(1) of SEBI LODR. The company confirmed that as of June 30, 2026, there are no unutilized funds remaining from any past public, rights, or preferential issues, or Qualified Institutional Placements (QIP). Since all previously raised capital has been fully deployed, the company reported no deviations from the objects stated in its offer documents. This is a routine compliance filing confirming the status of capital usage.

• Zero unutilized funds reported as of the quarter ended June 30, 2026
• Statement covers all past Public, Rights, and Preferential issues
• No deviation or variation reported in the use of proceeds
• Filing submitted in compliance with SEBI Circular dated December 24, 2019

Suncare Traders reported a net profit of ₹30.42 lacs for the quarter ended June 30, 2026, a recovery from the ₹131.87 lacs loss in the preceding quarter. However, revenue from operations saw a sharp year-on-year decline of 53.9%, falling to ₹51.41 lacs from ₹111.54 lacs in June 2025. The return to profitability was driven by a massive reduction in total expenses, which fell to ₹20.99 lacs from ₹162.48 lacs in the previous quarter. Despite the profit, the company's scale remains extremely small with a very low promoter holding of 4.69%.

• Net Profit of ₹30.42 lacs in Q1 FY27 compared to a loss of ₹131.87 lacs in Q4 FY26.
• Revenue from operations decreased 53.9% YoY to ₹51.41 lacs from ₹111.54 lacs.
• Total expenses were slashed to ₹20.99 lacs from ₹162.48 lacs in the sequential quarter.
• Employee benefit expenses reduced to ₹2.42 lacs from ₹9.37 lacs in the previous quarter.
• Paid-up equity share capital stands at ₹5,100 lacs (₹51 Cr) against a quarterly revenue of just ₹0.51 Cr.

Suncare Traders Ltd has scheduled a board meeting for August 7, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This is a routine regulatory filing under SEBI (LODR) Regulations. The company currently operates on thin margins with a TTM revenue of Rs 10 Cr and a TTM PAT of Rs 0 Cr. Investors should note the significantly low promoter holding of 4.69% as of June 2026.

• Board meeting scheduled for August 7, 2026, to review Q1 results.
• Financials to be reviewed cover the three-month period ending June 30, 2026.
• Company reported a TTM revenue of Rs 10 Cr with an operating margin of -0.5%.
• Promoter holding remains low at 4.69% as of the June 2026 quarter.

Suncare Traders Ltd has announced a transition in its top management, appointing Mr. Ramesh Salvi as the new Whole-time Director and Chief Financial Officer effective July 21, 2026. He replaces Mr. Harshad Rathod, who resigned citing personal commitments and other work preoccupations. The appointment is subject to shareholder approval at the upcoming Annual General Meeting. This change comes at a time when the company reports a small TTM revenue of Rs 10 Cr and a very low promoter holding of 4.69%.

• Appointment of Mr. Ramesh Salvi as WTD and CFO effective 21.07.2026
• Resignation of Mr. Harshad Rathod from WTD and CFO roles on 21.07.2026
• New appointee Mr. Ramesh Salvi is 32 years old with 5 years of experience in accounts and finance
• Mr. Ramesh Salvi holds 0% shares in the company as per initial disclosures
• The board meeting approving these changes concluded in 15 minutes (03:15 PM to 03:30 PM)